Cystectomy in 2016: Have we reached the limits

Poster Session 50

  • Location:
    Room Stockholm (Hall B2, level 0)
  • Chairs:
     P. Anderson, Melbourne (AU)
     M. Burger, Regensburg (DE)
     P. Zehnder, Luzern (CH)
  • Aims and objectives of this session

    Understand the state-of-the-art in cystectomy technique.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases

By: Gontero P.1, Pisano F.1, Marra G.1, Joniau S.2, Albersen M.2, Battaglia A.1, Destefanis P.1, Colombo R.3, Briganti A.3, Pellucchi F.3, Burgio G.3, Van Rhijn B.4, Van De Putte E.F.4, Esquena S.5, Palou J.5, Babjuk M.6, Fritsche H.M.7, Mayr R.7, Albers P.8, Niegisch G.8, De La Taille A.9, Masson-Lecomte A.9, Roupret M.10, Cai T.11, Witjes J.A.12, Bruins M.12, Baniel J.13, Mano R.13, Brausi M.14, Lapini A.15, Sessa F.15, Irani J.16, Stenzl A.17, Gakis G.17, Karnes J.18, Zattoni F.18, Scherr D.19, O’Malley P.19, Shariat S.20, Black P.21, Abdi H.21, Matveev V.B.22, Samuseva O.22, Peters M.22, Parekh D.23, Gonzalgo M.23, Fish M.24, Atiquallah A.24, Rink M.24

Institutes: 1A.o Città Della Salute E Della Scienza, University of Turin, Dept. of Urology, Turin, Italy, 2University Hospitals Leuven, Dept. of Oncologic and Reconstructive Urology, Leuven, Belgium, 3URI, IRCCS Ospedale San Raffaele, Milan, Italy, Dept. of Urology, Milan, Italy, 4Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital, Dept. of Surgical Oncology (Urology), Amsterdam, The Netherlands, 5Fundació Puigvert, Universitat Autònoma De Barcelona, Dept. of Uro Oncology, Barcelona, Spain, 6Hospital Motol and 2nd Faculty of Medicine, Charles University, Dept. of Urology, Prague, Czech Republic, 7Regensburg University, Dept. of Urology, Regensburg, Germany, 8Heinrich-Heine-University, Medical Faculty,, Dept. of Urology, Dusseldorf, Germany, 9CHU Mondor , Assistance Publique Des Hopitaux De Paris, Dept. of Urology, Paris, France, 10Hopital Pitiè-Salpetriere, Paris 6 University, Dept. of Urology, Paris, France, 11Osp. S. Chiara, Dept. of Urology, Trento, Italy, 12Radboud University Nijmegen Medical Centre, Dept. of Urology, Nijmegen, The Netherlands, 13Rabin Medical Centre, Dept. of Urology, Tel Aviv, Israel, 14Ospedale Di Carpi-Modena, Dept. of Urology, Carpi, Italy, 15AOU Careggi, University of Florence, Dept. of Urology, Florence, Italy, 16Centre Hospitalier Universitaire La Milétrie, University of Poitiers, Dept. of Urology, Poitiers, France, 17University Clinic of Tübingen, Dept. of Urology, Tübingen, Germany, 18Mayo Clinic, Rochester, MN, Dept. of Urology, Rochester, United States of America, 19Weill Medical College of Cornell University, New York, Dept. of Urology, New York, United States of America, 20Comprehensive Cancer Center Medical University Vienna, Dept. of Urology, Vienna, Austria, 21Vancouver Prostate Centre, Dept. of Urology, Vancouver, Canada, 22Dept of Urology and N.N. Blokhin Cancer Research Center, Dept. of Urology, Moscow, Russia, 23University of Miami Miller School of Medicine, Dept. of Urology, Miami, United States of America, 24Hamburg-Eppendor University Hospital, Dept. of Urology, Hamburg, Germany

Increased use of neoadjuvant chemotherapy for muscle invasive bladder cancer does not affect the rate of postoperative complications – results from the Swedish cystectomy registry

By: Jerlström T.1, Gårdmark T.2, Ströck V.3, Aljabery F.A-S.4, Hosseini A.A.5, Sherif A.6, Malmström P-U.7, Liedberg F.8, Jahnson S.4, Carringer M.1

Institutes: 1Faculty of Medicine and Health, Dept. of Urology, Örebro, Sweden, 2Danderyd Hospital, Karolinska Institutet, Dept. of Clinical Sciences , Stockholm, Sweden, 3Sahlgrenska University Hostpital, Dept. of Urology, Gothenburg, Sweden, 4Linköping University Hostpital, Dept. of Clinical and Experimental Medicine, Linköping, Sweden, 5Karolinska Institutet, Dept. of Molecular Medicine and Surgery, Section of Urology, Stockholm, Sweden, 6Umeå University, Dept. of Surgical and Perioperative Sciences, Urology and Andrology, Umeå, Sweden, 7Uppsala University, Dept. of Surgical Sciences, Urology, Uppsala, Sweden, 8Skåne University Hospital, Lund University, Dept. Translational Mediciney, Malmö, Sweden

Excellent continence and renal function outcomes can be maintained in patients who survived >10 yrs after diversion with an ileal orthotopic bladder substitute

By: Furrer M., Roth B., Nguyen D.P., Kiss B., Boxler S., Burkhard F.C., Thalmann G.N., Studer U.E.

Institutes: University Hospital Berne, Dept. of Urology, Berne, Switzerland

Validating the Bladder Utility Symptom Scale (BUSS): A multi attribute health state classification system for bladder cancer

By: Perlis N.1, Boehme K.1, Jamal M.2, Bremner K.3, Alibhai S.4, Finelli A.5, Ritvo P.6, Krahn M.3, Kulkarni G.1

Institutes: 1University of Toronto and University Health Network, Dept. of Surgical Oncology and Urology, Toronto, Canada, 2University of Toronto and Trillium Health Partners, Dept. of Urology, Toronto, Canada, 3University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, Canada, 4University Health Network, Dept. of Geriatriatrics, Toronto, Canada, 5University of Toronto and University Health Network, Dept. of Surgical Oncology, Division of Urology, Toronto, Canada, 6York University and Cancer Care Ontario, Dept. of Psychology, Toronto, Canada

Orthotopic ileal versus sigmoid neobladder in female patients, which is better regarding continence rates?

By: El-Hilaly H.2, El-Adawy M.2, Abdel Latif A.1, Metwally M.3, Mourad M.3, Mousa E.3

Institutes: 1Beni Suef, Dept. of Urology, Beni Suef, Egypt, 2Fayoum University, Dept of Urology, Fayoum, Egypt, 3El-Azahar University, Dept of Urology, Cairo, Egypt

What is the evidence for unusual recurrence patterns following totally intracorporeal robotic-assisted radical cystectomy? Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group

By: Collins J.1, Hosseini A.1, Adding C.1, Nyberg T.1, Koupparis A.2, Rowe E.2, Perry M.3, Issa R.3, Schumacher M.4, Wijburg C.5, Guru K.6, Canda A.E.7, Balbay M.D.8, Decaestecker K.9, Schwentner C.10, Stenzl A.10, Edeling S.11, Pokupić S.11, Mottrie A.12, Wiklund P.1

Institutes: 1Karolinska University Hospital, Dept. of Urology, Stockholm, Sweden, 2Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom, 3St Georges Hospital, Dept. of Urology, London, United Kingdom, 4Hirslanden Klinik, Dept. of Urology, Aarau, Switzerland, 5Rijnstate Hospital, Dept. of Urology, Arnhem, The Netherlands, 6Roswell Park Cancer Institute, Dept. of Urology, Buffalo, United States of America, 7Yildirim Beyazit University,, Dept. of Urology, Ankara, Turkey, 8Memorial Sisli Hospital, Dept. of Urology, Istanbul, Turkey, 9Ghent University Hospital, Dept. of Urology, Ghent, Belgium, 10Tubingen University Hospital, Dept. of Urology, Tubingen, Germany, 11Da Vinci Zentrum, Dept. of Urology, Hanover, Germany, 12O.L.V, Dept. of Urology, Aalst, Belgium

Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients

By: Fujii Y., Kihara K., Tanaka H., Saito K., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N.

Institutes: Tokyo Medical and Dental University Graduate School, Dept. of Urology, Tokyo, Japan

Preoperative favourable characteristics in bladder cancer patients cannot substitute the necessity of extended lymphadenectomy during radical cystectomy: A sensitivity curve and a survival analysis

By: Moschini M.1, Suardi N.1, Di Trapani E.1, Cucchiara V.1, Burgio G.1, Mirone V.2, Serretta V.3, Guido B.5, Shariat S.4, Briganti A.1, Montorsi F.1, Colombo R.1, Gallina A.1

Institutes: 1Uri, Irccs San Raffaele Scientific Institute, Dept. of Oncology and Urology, Milan, Italy, 2University Federico II, Dept. of Urology, Naples, Italy, 3Università Degli Studi Di Palermo, Dept. of Discipline and Surgical Oncology, Palermo, Italy, 4Medical University Vienna, Dept. of Urology, Vienna, Austria, 5Center For Reconstructive Urethral Surgery,, Dept. of Surgery, Arezzo, Italy

How to manage bowel division easily, cheaply and safely during intracorporeal robotic urinary diversion? LUCS: Lighting from Urethral (Cystoscope) Side!

By: Dal Moro F., Zattoni F.

Institutes: Universita’ di Padova – Azienda Ospedaliera, Dept. of Surgery, Oncology and Gastroenterology – Urology, Padua, Italy

Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer

By: Gakis G.1, Morgan T.2, Daneshmand S.3, Keegan K.A.4, Mischinger J.5, Schubert T.5, Zaid H.4, Hrbacek J.6, Clayman R.7, Ali-El-Dein B.8, Galland S.7, Olugbade K.2, Rink M.9, Fritsche H-M.10, Burger M.10, Chang S.4, Babjuk M.6, Thalmann G.11, Stenzl A.5, Efstathiou J.7

Institutes: 1University Hospital Tuebingen, Dept. of Urology, Tuebingen, Germany, 2University of Michigan, Dept. of Urology, Ann Arbor, United States of America, 3University of Southern California, Norris Comprehensive Cancer Cente, Dept. of Urology, Los Angeles, United States of America, 4Vanderbilt Universits Medical Center, Dept. of Urologic Surgery, Nashville, United States of America, 5University Hospital Tübingen, Dept. of Urology, Tübingen, Germany, 62nd Medical School, Charles University, Dept. of Urology, Prague, Czech Republic, 7Massachusetts General Hospital, Harvard Medical School, Dept. of Radiooncology, Boston, United States of America, 8Mansoura Clinic, Dept. of Urology and Nephrology, Mansoura, Egypt, 9University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 10University of Regensburg, Dept. of Urology, Regensburg, Germany, 11University of Berne, Dept. of Urology, Berne, Switzerland

Factors impacting local, distant and unusual recurrences after robot-assisted radical cystectomy: A detailed analysis from a tertiary referral center

By: Nguyen T.P.D., Al Hussein Al Awamlh B., Golombos D., O’Malley P., Khan F., Lewicki P., Scherr D.

Institutes: Weill Medical College of Cornell University, Dept. of Urology, New York, United States of America

Comparative effectiveness of robot-assisted and open radical cystectomy

By: Gandaglia G.1, Karl A.2, Novara G.3, De Groote R.4, Buchner A.2, D’ Hondt F.4, Montorsi F.5, Stief C.2, Mottrie A.6, Gratzke C.2

Institutes: 1Irccs Ospedale San Raffaele, Dept. of Oncology and Urology, Urological Research Institute, Milan, Italy, 2Ludwig-Maximilians-Univertisy, Dept. of Urology, Munich, Germany, 3OLV Vattikuti Robotic Surgery Institute, ORSI, Melle, Belgium, 4OLV Hospital, Dept. of Urology, Aalst, Belgium, 5IRCCS Ospedale San Raffaele, Dept. of Oncology and Urology, Urological Research Institute, Milan, Italy, 6OLV Hospital, OLV Vattikuti Robotic Surgery Institute, Dept. of Urology, ORSI, Aalst, Melle, Belgium

Radical cystectomy for bladder cancer vs non-malignant indications: Preoperative predictors of perioperative outcomes in a sample of 3269 patients

By: Vetterlein M.1, Meyer C.1, Löppenberg B.1, Sammon J.2, Hanske J.1, Menon M.2, Preston M.1, Chun F.3, Kibel A.1, Fisch M.3, Trinh Q-D.1

Institutes: 1Brigham and Women’s Hospital, Dept. of Urologic Surgery and Center For Surgery and Public Health, Boston, United States of America, 2Henry Ford Hospital / Health System, Vattikuti Institute of Urology, Center For Outomes Research, Analystics and Evaluation, Detroit, United States of America, 3University Medical Center Hamburg-Eppendorf, Dept. of Urologic Surgery and Center For Surgery and Public Health, Hamburg, Germany